Chemo Drugs Flashcards

(42 cards)

1
Q

Alkylating Agents Classes

A

Nitrogen mustards
Nitrosureas
Platinum Drugs
Miscellanous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Nitrogen Mustards

A

Melphalan, Cyclophosphamide, Ifosfamide, Chlorambucil and Estramustine

Men Can Inject Cocaine Everday

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Nitrosureas

A

Carmustine, Lomustine, Nimustine and Streptozocin (Streptozotocin

“Ustines” and streptozocin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Platinum Drugs

A

Carboplatin, Cisplatin, and Oxaliplatin

“Platins”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Miscellanous Alkylating Drugs

A

Busulfan, Procarbazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Nitrogen Mustards MOA

A
  • Link two Guanine molecules together causing DNA damage

(Azridium intm. –> Chloro)

N-7 Alkylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Nitrosurea Alkylating Agents MOA

A
  • Have a chloroethyl group that attaches to oxygen on Guanine
  • 06 alkylation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Streptozcin MOA

A
  • Has a methyl group
  • Get an O6 methylation to Guanine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Platinum Alkylating Agents MOA

A
  • Alkylate and cross link (inter or intra) two Guanine molecules
  • DNA damage –> N7 alkylation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Bulsulfan MOA

A

Remove mesylate (CH3SO3-) to form R–CH2+

Cause intra- and inter-crosslink of DNA molecules

N7 alkylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Procarbazine MOA

A

Form methyldiazonium ion (CH3-N+≡N) and methyl cation (CH3+)

Nonspecific alkylating agent which methylates guanine at O6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Antimetabolite Examples And…..

A

5-Fluorouracil (5-FU), capecitabine, gemcitabine, cytarabine and azacitidine

“ines”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Antimetabolite MOA

A

Incoporate into the double strand of the DNA molecule  Cause breaks  Destroy the DNA molecules

Miscoding due to incorporation into DNA/RNA (incorporation into DNA molecule)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Antimitotics Examples

A

Taxanes

Paclitaxel
Docetaxel

“axes”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Antimitotic MOA

A

Bind to free tubulin (mitotic spindle) –> Stable bonding
Produce stable microtubules
Inhibit microtubule disassembly (spindles stick)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Vinca Alkyloids Examples

A

Vinblastine, vincristine, vindesine and vinorelbine

“Vin”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MOA Vinca Alkyloids

A

Prevent microtube polymerization

  • Do not allow microtubule to form spindle

Inhibit formation of mitotic spindle

18
Q

Antitumour Antibiotics Examples

A
  • Antracyclines
  • DNA intercelating agents

Daunorubicin, doxorubicin, epirubicin, idarubicin and mitoxantrone

“ubicins”

19
Q

Anthracyclines MOA

A

Intercalate with DNA perpendicular to its longitudinal axis
Cause single and double stranded DNA cleavage

20
Q

PARP Inhibitors MOA

What does PARP Stand for?

A

Involved in DNA repair (inhibit DNA repair)

PARP: Poly (ADP-ribose) polymerase

21
Q

PARP Inhibitor Examples

A

Olaparib, rucaparib, niraparib, iniparib and talazoparib

“paribs” suffix

22
Q

PARP Inhibitors MOA

A

Block DNA repair in cancer cells and cause cancer cell death

23
Q

Targeted Tx Agents

A
  • Tyrosine Kinase Inhibitors

Monoclonal Antibodies

Apoptosis Inducing Agents

Angiogenesis Inhibitors

24
Q

Tyrosine Kinase Inhibitor Examples

A

Imatinib, Gefitinib, Ibrutinib

“inibs”

25
Monoclonal ANtibodies Examples
Prastuzumab, Pertuzumab, T-DM1, Bevacizumab, Rituximab "umabs"
26
Apoptosis Inducing Examples
Bortezomib, Oblimersen (nucleotide drug), THINK O's
27
Angiogenesis Inhibitors
Bevacizumab, Sunitinib
28
Tyrosine Kinase Inhibitor MOA
Tyrosine kinase (TK) domain is present in growth factor receptors, such as epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR), and signaling protein kinases such as Ras and Raf - Inhibit angiogensis
29
Immatinib MOA
Tyrosine-Kinase Inhibitor Inhibit BCR-ABL tyrosine kinase Inhibit proliferation and induce apoptosis in BCR-ABL positive cells
30
Gefitnib MOA
Inhibitor of epidermal growth factor receptor (EGFR) Signaling via EGF-EGFR promotes DNA synthesis, proliferation, migration and survival
31
Monoclonal Antibodies MOA
Bind to subdomain IV of Her2 protein
32
Pertuzumab MOA
Monoclonal antibody binds to subdomain II of Her2 protein Block homodimerization of Her2 and heterodimerization of Her2-Her3 - Inhibit Her2-signaling pathway and decrease cell growth THINK ER
33
Bortezomib MOA
Proteasome inhibitor and apoptosis-inducing agent Bind to 26S proteasome, prevent proteosome-mediated degradation of pro-apoptotic factors and induce apoptosis
34
Bevacizumab MOA
- Starve Cancer cells - Anti-angiogenesis monoclonal antibody blocking vascular endothelial growth factor (VEGF) - VEGF and its receptors (VEGFR) can induce and promote angiogenesis (take out either one)
35
Sunlitib MOA
Multiple-targeted tyrosine kinase inhibitor Inhibit VEGFR, platelet-derived growth factor receptor (PDGFR), colony stimulating factor receptor (CSFR) and tyrosine-protein kinase KIT (CD117) Angiogenesis inhibitor Sun --> Star --> Millions
36
PD-1 Mechanism
programmed cell death protein 1 (CD279) Surface protein on T-cells Prevent T-cells from killing other cells upon binding PD-L1 Check immune responses
37
PD- L1 Mechanism
programmed cell death ligand 1 (CD274 or B7-H1) Transmembrane protein Prevent T-cells from killing PD-L1-containging cells
38
PD-1 and PD-L1 Cancer Mechanism. Prevent cancer?
PD-L1 binds to PD-1 and inhibits T-cell killing of tumour cell Blocking PD-L1 allows T cell killing of tumour cell
39
Pd-1 Inhibitors
Pembrolizumab Nivolumab Cemiplimab
40
PD-L1 Inhibitors
Atezolizumab Avelumab Durvalumab
41
Tamoxifen MOA and What is it?
- Block ER and inhibit breast cancer cell growth May slightly increase the chance of getting uterine cancer (ER in breast to block function, if goes to uterus activates ER) - Hormonal Tx Think TAMMY
42
How do hormones promote cancer?
Hormones can bind estrogen receptor (ER) and progesterone receptor (PR) to promote cancer cell growth